http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33835112

Outgoing Links

Predicate Object
contentType Journal Article
issn 2076-393X
issueIdentifier 3
pageRange 403-
publicationName Vaccines
startingPage 403
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5bfb596263dad125ee0179de631c11de
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e81126cc75f58cc0091b687151b31997
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e9372eb8149e81c8218f12a2c4d0abcb
bibliographicCitation Jeon I, Lee JM, Shin KS, Kang T, Park MH, Seo H, Song B, Koh CH, Choi J, Shin YK, Kim BS, Kang CY. Enhanced Immunogenicity of Engineered HER2 Antigens Potentiates Antitumor Immune Responses. Vaccines (Basel). 2020 Jul 22;8(3). PMID: 32707803; PMCID: PMC7563373.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a723d3b51658cd6f2f01ca24dbab306
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4c59e4e70d111eaa675ad5471b288b6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d203e9d98273559ac18cbe2ea109039f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f2b7e6a8fa6e84f216e26f48e3f7f95
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d05175a01bf7db8932a1e10096e54e0d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0896-718X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39b4bf0b40c0559bf623586a00ec5602
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96c8e6ac7332d9519ef4527cc8ee40c5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_715de4de1c245910c172a6c71d6b3c66
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8388-4942
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af12cde917403a25d40c3064efcb2e0f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7d6ef412cba83afffb4fa66a1a9fbac
date 2020-07-22^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.3390/vaccines8030403
https://pubmed.ncbi.nlm.nih.gov/PMC7563373
https://pubmed.ncbi.nlm.nih.gov/32707803
isPartOf https://portal.issn.org/resource/ISSN/2076-393X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/42444
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Enhanced Immunogenicity of Engineered HER2 Antigens Potentiates Antitumor Immune Responses
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_beda6fe677b7a43d27c994ffcbd5e2d6
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6bc4a2b0864def75af655869e123a091
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7a0153350cba31da4ce6bfa8f8c68f72

Showing number of triples: 1 to 37 of 37.